Latest / The Vox Markets Podcast
2022: Q&A with hVIVO CEO, Mo Khan
Watch on YouTubehVIVO has secured a £2.7 million contract for its hLAB division to serve as the sole virology lab for a global Phase 2 influenza drug study involving 5,000 participants. This milestone marks hVIVO's largest standalone lab services contract, leveraging its expanded Canary Wharf facility.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.